SILVER SPRINGS - The Food and Drug Administration approved CalmScroll™ on Monday, the first prescription medication indicated specifically for acute and chronic symptoms associated with reading the news, including elevated pulse, doom-scrolling, and the sensation that it is only Tuesday.
"Patients reported a marked decrease in opening twelve tabs 'just to understand one thing,'" said FDA spokesperson Renata Cole. "We are not treating the underlying events. We are treating the experience of learning about them before coffee."
The once-daily pill works by mildly suppressing the amygdala's response to push notifications and by introducing a temporary belief that someone competent is handling things, even when evidence suggests otherwise. In clinical trials, participants noted a significant reduction in anxiety levels after taking CalmScroll, with some reporting they could finally finish their morning coffee without checking their phones.
"The first time I took it, I actually made it through the whole cup of coffee before opening my news app," said John Doe, a 45-year-old software engineer from Washington D.C. "I was surprised to find that the world didn't end."
The drug's mechanism of action involves a proprietary blend of calming agents and placebo effects. According to Wellstead Pharmaceuticals CEO, Dr. Elizabeth Hargrove, CalmScroll is designed to provide temporary relief while encouraging users to seek more balanced information sources.
"The key is not to suppress the truth but to help people process it in a healthier way," said Hargrove during an interview with The Associated Guess. "We believe this can lead to better-informed decisions and reduced stress."
Side effects include optimism, forgetting why you were angry, and in 4% of trial participants, accidentally liking a relative's post about politics. CalmScroll is contraindicated for journalists, pollsters, and anyone whose job requires knowing what happened.
Pharmaceutical giant Wellstead priced the drug at $890 per month, or "roughly what Americans already pay in emotional rent," according to a press release that analysts called "on brand." The company claims this price is justified by the high demand for mental health solutions and the unique nature of CalmScroll.
Public health advocates criticized the approval. "This is a bandage on a fire hose," said Dr. Amir Qasim of the Civic Attention Institute. "We should regulate the news, not sedate the audience."
Wellstead countered that CalmScroll pairs well with its companion app, which replaces headlines with photos of otters holding small rocks. Early adopters report sleeping through entire election cycles, which the company lists under Success Stories.
"Imagine waking up one day and realizing you've missed the whole debate," said Sarah Johnson, a 32-year-old marketing executive from Los Angeles. "It's like hitting snooze on the apocalypse."
Insurance coverage remains limited. Most plans will pay if a physician documents "significant Twitter exposure," defined as more than six quote-tweets before noon. However, many patients are finding that their out-of-pocket costs are prohibitive.
"The insurance companies are just as bad as the news," said Mike Smith, a 58-year-old retired teacher from Cleveland. "They want to know if I'm really reading too much."
Despite concerns, CalmScroll has gained popularity among those seeking relief from the daily deluge of information. The company reports that sales have exceeded expectations and are projected to continue growing as more people struggle with the overwhelming nature of modern news consumption.
In a twist of irony, Wellstead's own website features a banner ad for CalmScroll, encouraging users to "Find Peace in a Chaotic World." The ad copy reads: "Don't let the world stress you out. Take control with CalmScroll."
As the nation grapples with the implications of this new drug, one thing is clear: the war on information has taken an unexpected turn. While some see it as a necessary tool for mental health, others view it as a dangerous precedent in the ongoing battle to control public perception.
In the meantime, CalmScroll remains available by prescription only, and patients are advised to use it responsibly. "Remember," said Dr. Cole, "this is not a cure-all. It's just a way to give your brain a break."
